Introduction {#S0001}
============

Gastric cancer is the most common malignant tumor of the digestive system. China accounts for 42.6% of gastric cancer cases globally,[@CIT0001] and one of the main causes of death is metastasis of malignant tumors.[@CIT0002] With the continuous study of traditional Chinese medicine, numerous studies have illuminated that in cancer treatment it can be used to enhance the efficacy and diminish the side effects. Chen et al.[@CIT0003] Found that Huaier make the effective of HCC after curative liver resection which can extend RFS and reduce extrahepatic recurrence. In addition, Von Hagens et al.[@CIT0004] illustrated that in a phase I study, patients who have metastatic breast cancer with Long-term oral artesunate can consolidate the original curative effect and safety. Deeken et al.[@CIT0005] indicated that intravenous artesunate is 18 mg/kg which the treatment of solid tumor was well tolerated and diminishing the side effect. Compared to chemotherapy and radiotherapy in Western medicine, traditional Chinese medicine places considerable emphasis on overall regulation, and it has been proved to be an effective therapy for reducing side effects, improving the survival rate, and prolonging the survival period in cancer model systems. There are some anti-radiation traditional Chinese medicine in radiotherapy.[@CIT0006] Traditional Chinese medicine is proved to be efficacious in increasing the sensitivity to chemo- and radio-therapies.[@CIT0007] And evidence from the meta-analysis suggested that traditional Chinese medicine combined with chemotherapy has a positive effect on gastric cancer treatment.[@CIT0008] It can be seen that traditional Chinese medicine is of great significant for assitant-therapy to decline the side effect, safe and tolerable. The purpose of this review is to clarify the mechanism by which traditional Chinese medicine helps in the treatment of gastric cancer and prevention of metastasis as shown in [Table 1](#T0001){ref-type="table"}.Table 1Traditional Chinese Medicine On Gastric CancerIngredients of TCDTCDExperimentGastric cancer cell line and Experimental animalDosageEvent/MechanismEffectRefs&PMIDPrescriptionsXiaotan Sanjie recipeIn vivoBALB/C nude mice\
(5×106 MKN-45)1.496gVEGF-C and VEGFR-3Metastasis[@CIT0037]\
21425575HerbsLuteolinIn vitroMGC-803, HUVECs, Hs-746T10、20、30 μM\
\
(Main 30 μM)Suppressed Notch1-VEGF signaling\
\
Regulated NF-kB, AKT, and MMP-9 signalingAngiogenesis and VM formation\
Metastasis[@CIT0032]\
\
28655612Tanshinone IIA (TSN)In vitroSGC-79011、5、20 μg/LDownregulation of FOXM1Proliferation and Migration[@CIT0050]\
28184921BaicaleinIn vitroSGC-7901, MKN4515、30、60 μmol/LRegulated Bcl-2 and Bax\
Mitochondrial pathwayGrowth arrest\
Apoptosis[@CIT0054]\
26918059In vivoBALB/c nude mice\
(1×106 SGC-7901)15、50 mg/kgBaicaleinIn vitroSGC-7901 and MGC-803\<80 µMp38Invasion[@CIT0044]\
25502212Crude extractsColeusin factor (CF)In vitroBGC-82325、50、100 μMG0/G1\
Decreased cyclinD1, Bcl-2, and Bcl-xL, increased the p53, p21, and Rb.Growth arrest\
Proliferation and Apoptosis[@CIT0012]\
21093146Berberine hydrochloride (BER)In vitroAGS15 μMG2/M\
Enhanced IL −8 expression\
Affected ERK1/2, SAPK/JNK, JAK2 and AP-1 pathwayGrowth arrest\
Proliferation and Metastasis[@CIT0013]\
24063987AilanthoneIn vitroSGC-79010.5、1、2、4、 8 µMG2/M\
Bcl-2 and BaxGrowth arrest\
Apoptosis[@CIT0014]\
NoneCelastrus Orbiculatus extract (COE)In vitroAGS and BGC-823160 mg/LPI3K/Akt/mTOR/p70s6k pathway\
Induced the caspase-dependent mitochondrial pathwayProliferation\
Apoptosis[@CIT0020]\
28476678In vivoNude mice(GFP GC cells)40 mg/kgXiaotan Sanjie decoctionIn vitroGCSCs and MKN-451. 46、2.92 and 5.84 g/mLNotch-1、Hes1、VEGF and Ki-67Metastasis[@CIT0034]\
25278704In vivoSprague-dawley rats and nude mice\
(1×106 CD44+ and CD44- cells)1. 46、2.92 and 5.84 g/mLYiqi Huayu Jiedu decoctionIn vitroMGC-8032 mg/mLTGF-β/SmadInvasion and Metastasis[@CIT0039]\
28539961In vivoBALB/C nude mice\
(5×106 MGC-803)4 g/mL, 2 g/mLAqueous Huaier ExtractIn vitroSGC-7901 and MGC-8030.1、 0.2、 0.3、 0.5 mg/mL\
(main 0.5 mg/mL)Decreased N-cadherin and vimentinMetastasis[@CIT0048]\
\
\
29151976In vivoZebrafish\
(3×102 SGC-7901 labeled with CM-Dil)1 mg/mCelastrus Orbiculatus extract (COE)In vitroMGC-80320、40、80 µg/mLPromoted the expression of maspin Phosphoinositide 3-kinase/Akt/mTOR and MAPK signaling pathwaysApoptosis\
Invasion and Migration[@CIT0055]\
29387218CompoundsMatrinesIn vitroSGC-79010.25、0.5、1.0、2.0 mg/mLG0/G1\
BaxGrowth arrest\
Apoptosis[@CIT0010]\
21519796Gambogic acid (GA)In vitroBGC-8231.4 μMRepressed hTERT transcriptional activity via c-Myc and AktTelomerase activity[@CIT0018]\
18226852Crocodile choline (CCL)In vitroBGC-823, MGC-803, SGC-7901, MKN28 and GES110、20、40、60 µg/mLG2/M\
ΔΨm and ROS\
Notch pathwayGrowth arrest\
Apoptosis\
Proliferation and Metastasis[@CIT0022]\
\
28347224In vivoBALB/C nude mice\
(1×106 BGC-823)100 mg/kgGinsenosideIn vivoBALB/C nude mice\
(5×106 NUGC-4-RFP)1 mg/kgVEGF-C, VEGF-D and VEGFR-3Proliferation and Metastasis[@CIT0036]\
28314255MatrineIn vitroBCG-82350 μg/mLAffected vasodilator-stimulated phosphoprotein (VASP)Migration[@CIT0045]\
23685951SilibininIn vitroSGC-790150、100、200 μMDecreased MMP-2 and MMP-9Migration and Invasion[@CIT0043]\
29344204Astragalus polysaccharideIn vitroAGS200 μg/mLInhibited phosphorylated AKT (p-AKT) and MMP-9Metastasis[@CIT0049]\
29428665NaringeninIn vitroSGC-790120、40、80 μMRegulated AKT pathwayProliferation, Apoptosis, Migration, and Invasion[@CIT0052]\
26960693ComponentsPiperlongumine (PL)In vitroAGS and HGC-275、7.5、10 μM\
(Main 7.5 μM)G2/M\
Mediated by ROS and involves GADD45α, XIAP, and CHOP.\
Suppressed STAT3 and TERTGrowth arrest\
Proliferation and\
Apoptosis[@CIT0019]\
26874726In vivoNude mice\
(2×106 HGC-27)3.6 mg/kgPseudolaric acid B (PAB)In vitroBGC-823 and MKN-450.5、 2、5 、10 μM\
(10 μM)Suppressed PI3K/AKT, ERK1/2 and mitochondrial signaling\
\
Regulated MMP-9, HIF 1α, VEGF, VEGFR2, E-Cadherin and EzrinApoptosis\
\
\
Metastasis[@CIT0021]\
\
\
28132880In vivoBALB/C nude mice(1×106 BGC-823)30 mg/kgCurcuminIn vitroBGC-82315 μmol/LRegulated JNK-MAPK signal pathwayGrowth arrest[@CIT0061]\
25292057CurcuminIn vitroMKN45, AGS, GES-13.125、6.25、12.5、25.0 、50.0 μmol/LRegulated Cox-2 and NF-kB pathwayGrowth arrest[@CIT0063]\
25884903(-) - patchouli alcohol (PA)In vitroGES-110 μMDecreased IL-4,IL-2,TNF-alpha Increased IL-13Growth arrest[@CIT0064]\
27017292CurcuminIn vitroGC-MSCs30 μmol/LInhibited NF-κB/VEGF\
signalingAngiogenesis and Metastasis[@CIT0033]\
29312505Green tea polyphenolsIn vitroMKN-2810-4 M catechin equivalentsInhibited MMP-2、MMP-9Migration and Invasion[@CIT0042]\
29450132DehydroeffusolIn vitroSGC-7901 and AGS12、24、48 μMRegulated VE-cadherin and MMP-2Adhesion, Migration, and Invasion[@CIT0053]\
25982451In vivoBALB/C nude mice\
(4×106 SGC-7901)40、120 μg

Inhibition Of Proliferation Of Gastric Cancer Cells {#S0002}
===================================================

The proliferation of tumor cells is the foundation of tumor invasion and metastasis. Excessive proliferation of tumor cells at the primary focal center increases pressure and promotes invasion and metastasis in the direction of low pressure, resulting in metastasis to neighboring tissue and distant organs. Traditional Chinese medicine and its components can suppress the proliferation of gastric cancer by arresting the cell cycle, inhibiting telomerase activity, inducing apoptosis via the mitochondrial pathway, and regulating inflammation-related factors.

Cell Cycle Arrest {#S0002-S2001}
-----------------

Uncontrolled cell proliferation is one of the fundamental biological characteristics of tumors, based on dysregulation of the cell cycle. Various tumor components operate through cell cycle arrest. Cell cycle-dependent kinase (CDK2 and CDK4) plays a key role in cell cycle progression and is closely related to the entry of cells into S and G1 phase.[@CIT0009] Cell cycle arrest of tumor cells by traditional Chinese medicine is related to the loss of cell cycle-dependent protein kinase inhibitory factor activity, thereby inhibiting the CDK suppression signal and leading to cell cycle regulation disorder. Several studies have reported that[@CIT0010],[@CIT0011] matrines (including sophocarpine, oxysophocarpine, and sophoridine), astragalus polysaccharides (including ascorbic acid, glucose, and fructose), and cinobufotalin (an anti-cancer drug) can induce G1 cycle arrest. Sun et al.[@CIT0012] found that Coleusin factor induced cell cycle arrest at the G0/G1 stage in SGC-7901 cells. Other studies[@CIT0013],[@CIT0014] reported that berberine and ailanthone induced G2/M cell cycle arrest and inhibited the proliferation of gastric cancer cells.

Inhibition Of Telomerase Activity {#S0002-S2002}
---------------------------------

Recent studies have discovered that telomerase is expressed in more than 85% of cancers, making telomerase an attractive and viable target for the development of anti-cancer therapeutics.[@CIT0015],[@CIT0016] Telomerase may play an important role in the process of tumor proliferation. Moreover, inhibiting tumor cell telomerase activity through traditional Chinese medicine can effectively inhibit tumor cell proliferation and interfere with metastasis of tumor cells.

Çalışkan et al.[@CIT0017] found that telomerase activity regulates the expression of human telomerase reverse transcriptase (hTERT) in gastric cancer cells, and suggested that inhibiting telomerase activity may be a potential anti-cancer therapeutic mechanism. Another study[@CIT0018] utilized the PCR-TRAP method to evaluate telomerase activity in BGC-823 human gastric carcinoma cells, and found that gambogic acid (GA) can inhibit telomerase activity by inhibiting the phosphorylation of Akt and reducing the expression of hTERT. Duan et al.[@CIT0019] demonstrated that piperlongumine (PL) acts as an anti-cancer agent by inhibiting telomerase activity and cell proliferation in vitro and in vivo.

Mitochondrial Apoptosis Pathway {#S0002-S2003}
-------------------------------

Wang et al.[@CIT0020] found that the ethyl acetate extract of *Celastrus orbiculatus* (*C. orbiculatus* extract, COE) could change the mitochondrial membrane potential of the cell, downregulate the apoptosis-related proteins Bax and caspase, and increase the expression of bcl-2 and PI3K/Akt. These data suggest that the COE may inhibit the proliferation and metastasis of gastric cancer cells by inducing apoptosis. Pseudolaric acid (PAB) has been shown to promote the apoptosis of various cells. Wang et al.[@CIT0021] evaluated the molecular mechanism of the antitumor activity of PAB in human leukemia U937 cells. U937 cells were observed to be activated by the Bcl-2-mediated mitochondrial pathway, and activation of the caspase-dependent pathway was regulated by PAB. In addition, the activity of caspase-3 increased after PAB treatment. This study thus showed that PAB can enhance U937 cell apoptosis, at least in part through the activation of the mitochondrial apoptotic pathway. Mao et al.[@CIT0022] found that crocodile bile accelerated cell apoptosis via the mitochondrial apoptosis pathway. Simultaneously, it reduced the mitochondrial membrane potential, and increased the production of reactive oxygen species, the Bax/Bcl-2 ratio, the levels of activated caspase-3, and the release of cytochrome C. These data indicate that crocodile choline is a potent inhibitor of gastric cancer cells via the mitochondrial apoptosis pathway.

Other Aspects {#S0002-S2004}
-------------

The literature shows that traditional Chinese medicine also exhibits anti-gastric cancer effects through autophagy.[@CIT0023] Curcumin[@CIT0024] may inhibit proliferation and induce the autophagy and apoptosis in GC cells through MTT assay and transmission electron microscopy (TEM). Lei[@CIT0025] find that mulberry anthocyanins intervented SGC-7901 cells induced autophagy byTEM observation results.

Some studies have shown that traditional Chinese medicine can inhibit the effect of tumor cells through ROS. Kim DH et al[@CIT0026] reported for the first time that ISL induces apoptosis of renal cell carcinoma Caki cells by producing ROS, thus inducing p53 and inhibiting Stat3 signaling pathway. Silybin[@CIT0027] can induce caspase-dependent cell death in vitro and inhibit the growth of glioma in vivo through Ca2+/ROS/MAPK-mediated pathway.

There are other natural products, bitter melon extract (BME), suppressing the cancer proliferation via different mechanisms. Bhattacharya et al.[@CIT0028] shown that BME enhances NK cell-mediated HNSCC killing activity and reveals the potential immunomodulatory effects of BME. Muhammad et al.[@CIT0029] found that BME attains anti-tumor activity by induction of autophagy and AMPK/mTOR pathway. Subsequently, they demonstrated that BME oral feeding effectively inhibited cancer cell growth in isogenic and xenograft mouse models. In addition, Bhattacharya et al.[@CIT0030] shown that BME inhibited cell proliferation in BME orally-fed mouse tumors via lowering expression of proliferating cell nuclear antigen (PCNA) and c-Myc. Both of their studies indicates BME high potential clinical application.

Interference With Angiogenesis {#S0003}
==============================

By co-culturing endothelial cells with human or animal macrophages or supernatants, it was found that the angiogenic extracts caused chemotaxis of the peritoneal macrophages and human mononuclear cells in guinea pigs. These results imply that tumor extracts act indirectly to induce angiogenesis in vivo via their effect on host macrophages.[@CIT0031] Angiogenesis can be controlled by inhibiting the proliferation of vascular endothelial cells (VECs) and by regulating vascular growth factors.

Inhibition Of The Proliferation Of VECs {#S0003-S2001}
---------------------------------------

Angiogenesis is an essential pathological process in the metastasis of malignant tumors, and endothelial cell proliferation is the basis of angiogenesis. Therefore, the discovery and screening of drugs that inhibit the proliferation of VECs has become a focus of tumor clinical research. Zang et al.[@CIT0032] reported that Luteolin has an inhibitory effect on gastric cancer angiogenesis and Vasculogenic mimicry (VM) formation induced by inhibiting VEGF secretion, which is dependent on Notch1 expression. Huang et al.[@CIT0033] observed that curcumin could inhibit GC-MSC driven angiogenesis, which inhibits the proliferation of vascular endothelial cells, producing an anti-tumor effect. Lynne M Howells et al supported that in the treatment of patients with metastatic colorectal cancer. Curcumin is well safety and tolerated combining with FOLFOX chemotherapy. Bing et al.[@CIT0034] reported that Xiaotansanjie decoction attenuates microvessel density by inhibiting the proliferation of vascular endothelial cells in gastric cancer.

Angiogenic Factors {#S0003-S2002}
------------------

Under conditions of local hypoxia, several molecular responses are induced during tumor growth which activate hypoxia-inducible factors. The transcription factor HIF accumulates in endothelial cells under hypoxic conditions and binds to the VEGF promoter to induce VEGF expression, resulting in angiogenesis.[@CIT0035] Dai et al.[@CIT0036] reported that Ginsenoside Rg3 inhibits tumor growth and reduces lymph node metastasis by inhibiting the expression of VEGF-C, VEGF-D, and VEGFR-3 in an orthotopic mouse model of human gastric cancer. Pang et al.[@CIT0037] reported that xiaotan sanjie can inhibit proliferation of human gastric adenocarcinoma cells MKN-45 by attenuating tumor angiogenesis, which may be related to downregulation of the mRNA and protein expressions of VEGF-C and VEGFR-3.

Inhibition Of Gastric Cancer Cell Movement {#S0004}
==========================================

Local invasion and distant metastasis are the most important biological features of malignant carcinoma. Tumors with invasive growth can not only continue to grow at the original site, but also spread directly to the surrounding tissue, and can also spread to other parts of the body through a variety of ways. Therefore, inhibiting the metastasis of gastric cancer cells is particularly important in the treatment of tumor, including inhibition of the migration and invasion of gastric cancer cells and the adhesion of gastric cancer cells.

Migration And Invasion {#S0004-S2001}
----------------------

The migration and invasion capabilities of gastric cancer cells are associated with metastasis.[@CIT0038] Once proliferating gastric cancer cells reach a certain density, they will invade the adjacent basement membrane and extracellular matrix, penetrate blood vessels, and enter the circulatory system. Via migration through blood vessels, a small metastasis focus will be formed on a target organ.[@CIT0039] Other studies have also indicated that MMP-2 and MMP-9 facilitate cell migration and invasion. MMP-2 is involved in the metabolism of type IV collagen in the basement membrane, which is often the initial step in cancer invasion and metastasis.[@CIT0040],[@CIT0041] In addition, MMP-9, which is the main enzyme for degrading extracellular matrix (ECM), is an important mediator of migration and invasion for gastric cancer cells.[@CIT0042] Lu et al.[@CIT0043] reported that Silibinin acts by inhibiting the invasion and metastasis of human gastric cancer SGC-7901 cells, and by downregulating MMP-9 and MMP-2. Yan et al.[@CIT0044] found that Baicalein could inhibit the proliferative, adhesive, invasive, and migratory abilities of SGC-7901 cells. The underlying mechanism was the inhibition of the expression of MMP-9 and MMP-2 by suppressing the activity of the p38 signaling pathway. Zhang et al.[@CIT0045] demonstrated that alisol B can regulate phosphorylation of vasodilator-stimulated phosphoprotein (VASP) to inhibit gastric cancer cell adhesion and migration.

Adhesion {#S0004-S2002}
--------

An increase in cell adhesion molecule expression and degradation of the extracellular matrix can control cancer metastasis and reduce migration of cancer cells.

### Regulating The Expression Of Adhesion Molecules {#S0004-S2002-S3001}

Adhesion molecules regulate cell-cell adhesion, as well as adhesion of cells to the extracellular matrix. Reducing adhesion between malignant tumor cells and enhancing adhesion of tumor cells to host cells and the extracellular matrix are two of the basic mechanisms of malignant tumor metastasis. Adhesion is regulated by focal adhesion molecules including CD44 and E-Cad. One of the functions of CD44 is to regulate the adhesion and migration of tumor cells. In the active state, the cytoplasmic domain of CD44 interacts with the actin cytoskeleton, which promotes migration of tumor cells.[@CIT0046] Sun et al.[@CIT0047] found that HepG2 cells cultured with the serum of rats fed with Biejiajian Pills showed lower expressions of β-catenin protein both in the cytoplasm and the nuclei along with the inhibition of GSK-3β phosphorylation and reduced expression of CD44v6 and VEGF. Biejiajian Pills suppress the proliferation and invasiveness of hepatocellular carcinoma. Xu et al.[@CIT0048] found that Huaier could partly reverse the epithelial-mesenchymal transition (EMT) by decreasing the expression of the mesenchymal markers N-cadherin and vimentin and increasing the expression of the epithelial marker E-cadherin. Huaier extract significantly inhibited both the migratory and invasive abilities of gastric cancer cells. Ma et al Indicated that by Comprehensive clinical analysis, Huaier might enhance clinical therapeutic effects and decline the side ones with Gastrointestinal cancers.

### Inhibiting Extracellular Matrix Degradation {#S0004-S2002-S3002}

MMPs are the major zymogen family proteins that degrade tumor extracellular matrix (ECM). MMPs can promote tumor cell invasion of the ECM by degrading it, which permits tumor cells to migrate to other sites. Wu et al.[@CIT0049] found that the combination of Apatinib and AsPs could inhibit the expression of phosphorylated AKT (p-AKT) and MMP-9 expression. Apatinib, in combination with AsPs, showed enhanced inhibitory effects on cell proliferation, migration, and invasion compared with Apatinib monotherapy. Jiao et al.[@CIT0050] found that the migration and proliferation of the SGC-7901 cells were decreased after incubation with different concentrations of Tanshinone IIA (TSN) in a dose-dependent manner. Moreover, the expression levels of Ki-67, PCAN, MMP-2, MMP-9, and FOXM1 were decreased, and P21 was increased in the TSN-treated SGC-7901 cells.

Modulation Of Metastasis-Related Genes To Inhibit Metastasis {#S0004-S2003}
------------------------------------------------------------

Inhibition of gastric cancer cell metastasis can be achieved by regulating metastasis-related gene expression in gastric cancer. In 2003, Ishikawa et al.[@CIT0051] reported that VEGF-C and -D genes may be associated with lymphatic metastasis of early gastric cancer, which suggested that VEGF-C and -D genes inhibit tumor metastasis. Dai et al.[@CIT0036] reported that ginsenosides can target vegf-c, vegf-d, and vegfr-3 genes in mouse models of human gastric cancer cells and inhibit the progression and metastasis of malignant tumors. Bao et al.[@CIT0052] reported that naringenin may inhibit the migration and invasion of human gastric cancer SGC-7901 cells by reducing the expression of metastasis related genes MMP-2 and MMP-9. Liu et al.[@CIT0053] reported that Dehydroeffusol can significantly inhibit the migration and invasion of gastric cancer cells in vivo and in vitro. Dehydroeffusol can inhibit gene promoter activity, influence the expression of the vasculogenic mimicry master gene VE-cadherin, and significantly reduce the expression of metastasis associated genes in gastric cancer cells (MMP2), thus effectively inhibiting gastric cancer metastasis. The proliferation of gastric cancer cells not only increases the pressure between gastric cancer cells, but also enhances metastasis. Most traditional Chinese medicines exhibit their anti-metastasis effect by regulating the relevant oncogenes and anti-oncogenes to further inhibit cellular proliferation and induce apoptosis. Recent studies have demonstrated that metastasis-associated genes include Bcl-2, Bax, maspin, and p53. Mu et al.[@CIT0054] showed that baicalein has anti-apoptotic activity by downregulating Bcl-2 and upregulating Bax in SGC-7901 cells. Qian et al.[@CIT0055] indicated that COE could induce apoptosis of human gastric cancer MGC-803 cells overexpressing the maspin gene.

Regulation Of Inflammation-Related Factors {#S0005}
==========================================

Cancer-related inflammation can promote tumorigenesis, tumor growth, and tumor metastasis in many types of cancers. Therefore, inhibiting cancer-related inflammation significantly improves the effects of cancer therapy. It is known that neoplastic cells often over-express proinflammatory mediators including proteases, eicosanoids, cytokines, and chemokines.[@CIT0056] Moreover, 40 years ago, the phenomenon of TNF-mediated cell death in vitro and its physiological and pathophysiological effects were first described.[@CIT0057],[@CIT0058] Blocking TNF causes TNFR1 to no longer activate MAPK and NF-κB signaling, resulting in downregulation of proinflammatory genes.[@CIT0059] Curcumin plays an anti-cancer role by inhibiting the occurrence, progression, and metastasis of various cancers, and inhibits cancer by two main processes that affect angiogenesis and tumor growth. Curcumin inhibits lymph node metastasis in gastric cancer, and its pleiotropic activity is mediated by modulating proinflammatory cytokines, and other signaling molecules, Human protein STAT3, NF-κB, COX-2, 5-LOX, C- reactive protein, prostaglandin E (2), prostatic specific antigen, adhesion molecule, phosphorylase kinase, triglyceride, transforming growth factor beta, ET-1 HO-1, creatinine, ALT, and AST.[@CIT0060]--[@CIT0063] Patchouli alcohol (PA), the main active ingredient of *Pogostemonis herba*, has anti-*Helicobacter pylori* and gastroprotective functions. In addition, PA significantly reduced the levels of pro-inflammatory cytokines such as interleukin −4 (IL-4), IL-2, and tumor necrosis factor (TNF-alpha), and increased the level of the anti-inflammatory cytokine IL-13 in GES-1 cells. To a certain extent, reducing the inflammatory reaction of the gastric mucosa can help block the precancerous lesions of gastric cancer.[@CIT0064]

Conclusion {#S0006}
==========

This article summarizes how Chinese medicine can intervene at multiple levels and affect multiple targets to influence the metastasis of gastric cancer as shown in [Figure 1](#F0001){ref-type="fig"}. However, it is difficult to confirm the active ingredients of traditional Chinese medicines due to their multimodal anti-tumor effects and complex composition, thus greatly limiting their potential. Additionally, clinical research for traditional Chinese medicine still lacks in-depth study and evaluation criteria, and as a result its authenticity is largely unrecognized. These findings suggest that the multi-effects of traditional Chinese medicine should be combined with those of Western medicine, allowing integrative medicine to be used to control tumors. It is expected that further rigorous research will demonstrate that traditional Chinese medicine has clinical significance for treatment of the metastasis of gastric cancer and will lead to improvement of preventive measures.Figure 1Mechanisms underlying therapeutic effects of traditional Chinese medicine on gastric cancer. (**A**) General approach of mechanisms. (**B**) Detailed approach of mechanisms.

With the continuous discovery and deeper exploration of the mechanism of gastric cancer and identification of the new molecular targets, the target of Chinese medicine in gastric cancer has been found, and the effects of traditional Chinese medicine have been determined at the molecular level, which provides the basis for clinical applications of traditional Chinese medicine.
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